PATENT CLAIM ANALYSIS

Application Number: 15873293
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "255050"]

Abstract:
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.

Claim (Index 17):
A method of treating or preventing a disease or condition associated with aberrant EGFR activity in a subject comprising administering to a subject an effective amount of at least one compound according to  claim 1 .

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15873255', '14913508', '16067444', '11048657', '14382074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7562765485014318
- 35 USC 102 Novelty (BERT): 0.5385755035204692
- Combined Prediction Score: 0.7345064440033355
- Mean Citation Score: 330.21107600000005
- Max Citation Score: 363.78082
- Similarity Product: 248.3556948528314

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test